Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

MXCT

Maxcyte (MXCT)

Maxcyte Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:MXCT
FechaHoraFuenteTítuloSímboloCompañía
23/12/202401:00RNS Regulatory NewsMaxCyte, Inc. MaxCyte Announces Retirement of Board MemberLSE:MXCTMaxcyte Inc
19/12/202410:26RNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
09/12/202406:29Alliance NewsAlliance NewsMaxCyte ups core revenue guidance for 2024 as eyes 2025 cost savingsLSE:MXCTMaxcyte Inc
09/12/202401:00RNS Regulatory NewsMaxCyte, Inc. MaxCyte Streamlines Operations and Raises GuidanceLSE:MXCTMaxcyte Inc
02/12/202411:09RNS Regulatory NewsMaxCyte, Inc. Total Voting Rights and Block Listing ReturnLSE:MXCTMaxcyte Inc
08/11/202408:41Alliance NewsAlliance NewsMaxCyte third-quarter profit falls amid surging costsLSE:MXCTMaxcyte Inc
07/11/202401:00RNS Regulatory NewsMaxCyte, Inc. Filing of 10Q formLSE:MXCTMaxcyte Inc
07/11/202401:00RNS Regulatory NewsMaxCyte, Inc. Third Quarter 2024 Financial ResultsLSE:MXCTMaxcyte Inc
06/11/202415:05UK RegulatoryMaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 GuidanceLSE:MXCTMaxcyte Inc
06/11/202407:43RNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
04/11/202407:23RNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
31/10/202407:05RNS Non-RegulatoryMaxCyte, Inc. Upcoming Investor ConferencesLSE:MXCTMaxcyte Inc
18/10/202403:24RNS Regulatory NewsMaxCyte, Inc. Grant of Options and Restricted Stock UnitsLSE:MXCTMaxcyte Inc
15/10/202407:05RNS Regulatory NewsMaxCyte, Inc. MaxCyte Appoints Cynthia Collins to BoardLSE:MXCTMaxcyte Inc
11/10/202407:00RNS Regulatory NewsMaxCyte, Inc. Notice of ResultsLSE:MXCTMaxcyte Inc
10/10/202407:05RNS Regulatory NewsMaxCyte, Inc. MaxCyte Appoints Ali Soleymannezhad as CCOLSE:MXCTMaxcyte Inc
16/09/202404:33Alliance NewsAlliance NewsMaxCyte touts strategic platform license deal with Kamau TherapeuticsLSE:MXCTMaxcyte Inc
16/09/202401:00RNS Regulatory NewsMaxCyte, Inc. TR-1: Notification of major holdingsLSE:MXCTMaxcyte Inc
16/09/202401:00RNS Regulatory NewsMaxCyte, Inc. Signing of Strategic Platform LicenseLSE:MXCTMaxcyte Inc
06/09/202405:33RNS Non-RegulatoryMaxCyte, Inc. Bioprocessing Conference ParticipationLSE:MXCTMaxcyte Inc
07/08/202408:10Alliance NewsAlliance NewsMaxCyte reaffirms guidance as revenue jumps 24% in first halfLSE:MXCTMaxcyte Inc
07/08/202401:05RNS Regulatory NewsMaxCyte, Inc. Filing of Form 10-QLSE:MXCTMaxcyte Inc
07/08/202401:00RNS Regulatory NewsMaxCyte, Inc. Second Quarter and Half-Year ResultsLSE:MXCTMaxcyte Inc
09/07/202403:14RNS Regulatory NewsMaxCyte, Inc. Change of Name of Nominated Adviser and BrokerLSE:MXCTMaxcyte Inc
27/06/202408:34RNS Regulatory NewsMaxCyte, Inc. Publication of Annual ReportLSE:MXCTMaxcyte Inc
12/06/202401:00RNS Regulatory NewsMaxCyte, Inc. Result of AGMLSE:MXCTMaxcyte Inc
11/06/202405:10Alliance NewsAlliance NewsIN BRIEF: MaxCyte CEO Maher Masoud buys 100,000 sharesLSE:MXCTMaxcyte Inc
11/06/202401:00RNS Regulatory NewsMaxCyte, Inc. PDMR DealingLSE:MXCTMaxcyte Inc
29/05/202407:05RNS Regulatory NewsMaxCyte, Inc. Participation in Upcoming Investor ConferenceLSE:MXCTMaxcyte Inc
22/05/202415:51Alliance NewsAlliance NewsIN BRIEF: MaxCyte inks deal with Legend Biotech for tech supplyLSE:MXCTMaxcyte Inc
 Showing the most relevant articles for your search:LSE:MXCT

Su Consulta Reciente

Delayed Upgrade Clock